[Do critical pathways improve outcomes of patients with cardiac failure?]

Antonietta Barbieri1, Erika Milan, Maria Grazia Cattaneo

  • 1SC Qualità e Appropriatezza Prescrittiva - Presidio Ospedaliero S. Andrea ASL VC, Vercelli. antonella.barbieri@aslvc.piemonte.it

Igiene E Sanita Pubblica
|April 18, 2012
PubMed

Insights

Critical pathways significantly reduce mortality and hospital stays for cardiac failure patients. This meta-analysis shows improved outcomes and lower costs compared to standard care, enhancing patient management.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Cardiac failure is a growing public health concern with increasing incidence and prevalence.
  • Despite advances, effective management strategies for cardiac failure are crucial.

Purpose of the Study:

  • To evaluate the impact of critical pathways versus standard care in managing cardiac failure patients.
  • To assess critical pathways' effects on mortality, hospital stay, costs, and readmissions.

Main Methods:

  • A meta-analysis of eleven studies involving 5,460 patients.
  • Databases searched: Medline, Embase, CINAHL, Cochrane.
  • Study quality assessed using Jadad method and New Castle Ottawa Scale.

Main Results:

  • Critical pathways led to lower hospital and six-month mortality rates.
  • Significant improvements observed in reduced length of hospital stay and direct costs.
  • Lower readmission rates at one, three, and six months were associated with critical pathways.

Conclusions:

  • Critical pathways enhance the quality of care for cardiac failure patients.
  • Further research is recommended to identify specific mechanisms within care pathways that drive these improvements.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...